If you have been reading about bioavailability and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-05-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
==== Cephalosporin synthesis ==== D-amino acid oxidase is used in biotechnology primarily to produce antibiotics called cephalosporins. The use of D-amino acid oxidase for the creation of antibiotics is a patented production of antibiotics and started in 1970. Originally the D-amino acid oxidase used in this process was taken from a pig’s kidney and was given the name pkDAAO. pkDAAO is very unstable throughout the processes of antibiotic synthesis and therefore gave a low yield of antibiotics. Through continued research a more successful form of D-amino acid oxidase was discovered from a yeast species named Rhodotorula gracilis and therefore was named RgDAAO. RgDAAO is now used as the primary D-amino acid oxidase used in cephalosporin antibiotics because the immobilization on commercial ion exchange resins creates a more stable system that yields much higher amounts of antibiotics.
Acepromazine † — although it is mostly used in veterinary medicine. Chlorpromazine (Thorazine) Cyamemazine † Dixyrazine † Fluphenazine Levomepromazine‡ Mesoridazine (discontinued)† Perazine Pericyazine‡ Perphenazine Pipotiazine ‡ Prochlorperazine Promazine (discontinued) Promethazine Prothipendyl † Thioproperazine‡ (only English-speaking country it is available in is Canada) Thioridazine (discontinued) Trifluoperazine Triflupromazine (discontinued)†
=== Hypothalamic–hypophyseal portal system === Dopamine released at TIDA terminals enters the long portal veins and is delivered directly to lactotrophs of the anterior pituitary. An additional source of dopamine reaches the anterior lobe from the neurointermediate lobe via short portal vessels. Severing or compressing the pituitary stalk eliminates dopamine delivery and causes prolactin levels to rise sharply, an effect opposite to that seen with every other anterior pituitary hormone.
Sources: en.wikipedia.org
Boswellia frereana grows in northern Somalia. Boswellia occulta: Somalia. For a long time Somali harvesters considered Boswellia occulta to be the same species as Boswellia carteri even though their shapes are different, and sold resins from both species as the same thing. However in 2019, it was clear that the chemical compositions of their essential oils are completely different. Boswellia sacra: Somalia, South Arabia. Boswellia bhaw-dajiana (older spelling Boswellia bhau-dajiana) It is a synonym of Boswellia sacra Boswellia carteri (older spelling Boswellia carterii): It was long considered an independent species, but in the 1980s it was determined to be a synonym of Boswellia sacra. Boswellia serrata (synonym Boswellia thurifera): India. Boswellia papyrifera: Ethiopia, Eritrea, Sudan. Recent studies indicate that frankincense tree populations are declining, partly from overexploitation. Heavily tapped trees produce seeds that germinate at only 16% while seeds of trees that had not been tapped germinate at more than 80%. In addition, burning, grazing, and attacks by the longhorn beetle have reduced the tree population. Clearing of frankincense woodlands for conversion to agriculture is also a major threat.
Copper is the traditional material for the boiling vessel for two main reasons: firstly because copper transfers heat quickly and evenly; secondly because the bubbles produced during boiling, which could act as an insulator against the heat, do not cling to the surface of copper, so the wort is heated in a consistent manner. The simplest boil kettles are direct-fired, with a burner underneath. These can produce a vigorous and favourable boil, but are also apt to scorch the wort where the flame touches the kettle, causing caramelisation and making cleanup difficult. Most breweries use a steam-fired kettle, which uses steam jackets in the kettle to boil the wort. Breweries usually have a boiling unit either inside or outside of the kettle, usually a tall, thin cylinder with vertical tubes, called a calandria, through which wort is pumped.
==== Rivaroxaban binding to factor Xa ==== Rivaroxaban binding to FXa is mediated through two hydrogen bonds to the amino acid Gly-219. These two hydrogen bonds serve an important role directing the drug into the S1 and S4 subsites of FXa. The first hydrogen bond is a strong interaction which comes from the carbonyl oxygen of the oxazolidinone core of rivaroxaban. The second hydrogen bond is a weaker interaction and comes from the amino group of the clorothiophene carboxamide moiety. These two hydrogen bonds result in the drug forming an L-shape and fits in the S1 and S4 pockets. The amino acids residues Phe-174, Tyr-99, and Trp-215 form a narrow hydrophobic channel that is the S4 binding pocket. The morpholinone part of rivaroxaban is “sandwiched” between amino acids Tyr-99 and Phe-174 and the aryl ring of rivaroxaban is oriented perpendicularly across Trp-215. The morpholinone carbonyl group does not have a direct interaction to the FXa backbone, instead, it contributes to a planarization of the morpholinone ring and therefore supports rivaroxaban to be sandwiched between the two amino acids.
Sources: en.wikipedia.org
=== Operation Enduring Freedom, 2007–2008 === In January 2007, then Maj. Gen. David M. Rodriguez deployed the division headquarters to Bagram, Afghanistan, accompanied by 4th BCT and the Aviation Brigade, as Commander, Combined Joint Task Force-82 (CJTF-82)and Regional Command – East for Operation Enduring Freedom VIII. The 3d BCT, 10th Mountain Division (Light Infantry) was extended for 120 days to increase the troop strength against the Taliban spring offensive. Extended to 15-month deployment, 4th BCT, which included 1–508th Infantry Regiment, 2–508th Infantry Regiment, and 4–73rd Cavalry Regiment, 2–321st Field Artillery, and 782nd Brigade Support Battalion, was commanded by then Col. Martin P. Schweitzer and remained in Khowst Province from January 2007 until April 2008. The 2–508th IR worked to establish and maintain firebases in and around the Ghazni province while actively patrolling their operational area. The 1–508 PIR served in Regional Command-South. Working mostly out of Kandahar province as the theater tactical force, they mentored the Afghan National Security Force (ANSF), conducting combined operations with both ANSF and NATO partners in the Helmand province. Supporting the division were the 36th Engineer Brigade, and the 43d Area Support Group.
(Despite this being how it works in theory, hair samples from dark areas of liver chestnut and dark red chestnut horses were found to contain both types of melanin.) In general, alleles that create fully functional MC1R proteins are inherited dominantly and result in a black-based coat color ("E"), while mutated alleles that create "dysfunctional" MC1R are recessive and result in a lighter coat color ("e"). Normally MC1R would bind to the Melanocyte-stimulating hormone (MSH) which is released by the pituitary gland and stimulates the production and release of melanin in skin and hair. Red hair color in horses ("e") is created by a missense mutation in the code for MC1R, which results in a protein that cannot bind to MSH. When only mutant copies ("e) of the gene are available, non-functional MC1R proteins are produced. As a result, no black pigment is deposited into the hair and the entire coat is red-based. However, the skin of chestnut horses is still generally black, unless affected by other genes. Some chestnut foals are also born with lighter eyes and lightened skin, which darken not long after birth. This is not the same as the blue eyes and pink skin seen at birth in foals carrying the champagne gene. It is a genetic mechanism not fully understood, but may be related to the pheomelanistic characteristics of "e". Though "E" allows the production of black pigment, it can also allow for red pigment in some parts of the animal as seen in bay horses.
The diminished Byzantine state survived for another century through diplomacy and favourable external developments. The Ottomans gradually subjugated Anatolia and simultaneously expanded into Europe from 1354, taking Philippopolis in 1363, Adrianopolis in 1369, and Thessalonica in 1387. Dynastic struggles increasingly depended on Venetian, Genoese, and Ottoman backing. After Manuel II (r. 1391–1425) refused to pay homage to Sultan Bayezid I in 1394, Constantinople was besieged until the rampaging warlord Timur decisively defeated Bayezid in 1402, with the city perilously close to surrender. After Ankara, Manuel II gained nearly two decades of relative peace as Ottoman succession struggles and later Anatolian campaigns occupied the sultans. In 1421, his unsuccessful backing of the claimant Mustafa Çelebi led to a renewed Ottoman assault. Although John VIII (r. 1425–1448) reconciled with the Catholic West at the Council of Florence, his empire steadily diminished. In 1452, Sultan Mehmed II resolved to capture Constantinople, and laid siege early the following year. On 29 May 1453, the city was captured, the last emperor, Constantine XI, died in battle, and the Byzantine Empire ended.
Histiocytic diseases in dogs are a group of diseases in dogs which may involve the skin, and which can be difficult to differentiate from granulomatous, reactive inflammatory or lymphoproliferative diseases. The clinical presentation and behaviour as well as response to therapy vary greatly among the syndromes. There are at least four well-defined canine histiocytic diseases:
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.